Lixiang Zhao

Dr. Lixiang Zhao


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in mBio
Verified
Journal Article
Open access
YZYongxiang Zhao
Yongxiang Zhao
Baochao FanBaochao Fan
Baochao Fan
XSXu Song
Xu Song
JGJie Gao
Jie Gao
RGRongli Guo
Rongli Guo
Bin LiBin Li
Bin Li
Porcine epidemic diarrhea virus (PEDV) continues to harm the global swine industry. It is important to develop a highly effective vaccine to control PEDV infection. Here, we report a PEDV spike (S) mRNA vaccine that primes a potent antibody response and antigen-specific T-cell responses in immunized piglets. Active and passive immunization can protect piglets against PED following the virus challenge. This study highlights the efficiency of the PEDV-S mRNA vaccine and represents a viable approach for developing an efficient PEDV vaccine.

1 May 2009 in Microbiology
Verified
Journal Article
Closed access
LZLixiang Zhao
Lixiang Zhao
SGSong Gao
Song Gao
HHHaixia Huan
Haixia Huan
XXXiaojing Xu
Xiaojing Xu
XZXiaoping Zhu
Xiaoping Zhu
XLXiufan Liu
Xiufan Liu
Avian pathogenic Escherichia coli (APEC) and uropathogenic E. coli (UPEC) establish infections in extraintestinal habitats of different hosts. As the diversity, epidemiological sources and evolutionary origins of extraintestinal pathogenic E. coli (ExPEC) are so far only partially defined, in the present study,100 APEC isolates and 202 UPEC isolates were compared by their content of virulence genes and phylogenetic groups. The two groups showed substantial overlap in terms of their serogroups, phylogenetic groups and virulence genotypes, including their possession of certain genes associated with large transmissible plasmids of APEC. In a chicken challenge model, both UPEC U17 and APEC E058 had similar LD50, demonstrating that UPEC U17 had the potential to cause significant disease in poultry. To gain further information about the similarities between UPEC and APEC, the in vivo expression of 152 specific genes of UPEC U17 and APEC E058 in both a murine urinary tract infection (UTI) model and a chicken challenge model was compared with that of these strains grown statically to exponential phase in rich medium. It was found that in the same model (murine UTI or chicken challenge), various genes of UPEC U17 and APEC E058 showed a similar tendency of expression. Several iron-related genes were upregulated in the UTI model and/or chicken challenge model, indicating that iron acquisition is important for E. coli to survive in blood or the urinary tract. Based on these results, the potential for APEC to act as human UPEC or as a reservoir of virulence genes for UPEC should be considered. Further, this study compared the transcriptional profile of virulence genes among APEC and UPEC in vivo.

1 September 2009 in Urology
Verified
Journal Article
Closed access
LZLixiang Zhao
Lixiang Zhao
XCXiang Chen
Xiang Chen
XZXiaoping Zhu
Xiaoping Zhu
WYWeixia Yang
Weixia Yang
LDLanmei Dong
Lanmei Dong
XLXiufan Liu
Xiufan Liu

3 November 2014 in Leukemia
Verified
Journal Article
Open access
PDF file
YLY Liu
Y Liu
YWY Wu
Y Wu
YWY Wang
Y Wang
YCY Cai
Y Cai
BHB Hu
B Hu
HLHaiyan Liu
Haiyan Liu
IL-35 is a newly discovered inhibitory cytokine secreted by regulatory T cells (Tregs) and may have therapeutic potential in several inflammatory disorders. Acute graft-versus-host disease (aGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation and caused by donor T cells and inflammatory cytokines. The role of IL-35 in aGVHD is still unknown. Here we demonstrate that IL-35 overexpression suppresses CD4+ effector T-cell activation, leading to a reduction in alloreactive T-cell responses and aGVHD severity. It also leads to the expansion of CD4+Foxp3+ Tregs in the aGVHD target organs. Furthermore, IL-35 overexpression results in a selective decrease in the frequency of Th1 cells and an increase of IL-10-producing CD4+ T cells in aGVHD target tissues. Serum levels of TNF-α, IFN-γ, IL-6, IL-22 and IL-23 decrease and IL-10 increases in response to IL-35. Most importantly, IL-35 preserves graft-versus-leukemia effect. Finally, aGVHD grade 2–4 patients have decreased serum IL-35 levels comparing with time-matched patients with aGVHD grade 0–1. Our findings indicate that IL-35 has an important role in reducing aGVHD through promoting the expansion of Tregs and repressing Th1 responses, and should be investigated as the therapeutic strategy for aGVHD.

4 August 2014 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
QCQiao Cheng
Qiao Cheng
SMShoubao Ma
Shoubao Ma
DLDandan Lin
Dandan Lin
YMYu Mei
Yu Mei
HGHuanle Gong
Huanle Gong
HLHaiyan Liu
Haiyan Liu

1 June 2017 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
YMYu Mei
Yu Mei
LZLixiang Zhao
Lixiang Zhao
YLYonghao Liu
Yonghao Liu
HGHuanle Gong
Huanle Gong
YSYuan Song
Yuan Song
HLHaiyan Liu
Haiyan Liu
Stimulation of tumor-specific responses in both CD4+ and CD8+ T cells has been a challenge for effective tumor vaccines. We designed a vaccine vector containing the AIDA-1 autotransporter and DNA vaccine elements, generating a murine melanoma vaccine that was delivered by the attenuated Salmonella strain SL7207. Growth of murine subcutaneous melanoma was significantly inhibited by intranasal immunization with the Salmonella tumor vaccine. The vaccine activated tumor-specific CD4+ and CD8+ T-cell responses, with increased T-cell proliferation, tumor antigen–specific Th1 cytokine production, increased percentages of tetramer positive cells, and cytotoxicity. CD4+ or CD8+ T-cell depletion resulted in the loss of antitumor activity of the Salmonella tumor vaccine, suggesting that the efficacy of the vaccine was dependent on both CD4+ and CD8+ T cells. Lung metastasis of the tumor was also inhibited by vaccine treatment. Similarly, the percentages of tumor-specific Th1 cytokine production by CD4+ and CD8+ T cells in the spleen, tumor, and bronchoalveolar lavage were increased after vaccine treatment. Tumor-specific proliferation of CD4+ and CD8+ T cells was also promoted by the vaccine. Tetramer staining and cytotoxicity assay showed enhanced tumor-specific CD8+ T-cell response after vaccine treatment. Therefore, the Salmonella tumor vaccine could activate both tumor-specific CD4+ and CD8+ T-cell responses. This vaccine strategy may be widely applicable to the development of oral or nasal vaccines against tumors. Cancer Immunol Res; 5(6); 503–14. ©2017 AACR.